Description
An impurity of Linagliptin, a novel potent and selective dipeptidyl peptidase-4 (DPP-4) inhibitor with potential use in the treatment of type 2 diabetes.
Synonyms
8-Bromo-7-(but-2-yn-1-yl)-3-methyl-1H-purine-2,6(3H,7H)-dione; 8-Bromo-7-(2-butyn-1-yl)-3-methylxanthine
IUPAC Name
8-bromo-7-but-2-ynyl-3-methylpurine-2,6-dione
Molecular Formula
C10H9BrN4O2
Canonical SMILES
CC#CCN1C2=C(N=C1Br)N(C(=O)NC2=O)C
InChI
InChI=1S/C10H9BrN4O2/c1-3-4-5-15-6-7(12-9(15)11)14(2)10(17)13-8(6)16/h5H2,1-2H3,(H,13,16,17)
InChIKey
HFZOBQSHTNNKFY-UHFFFAOYSA-N
Solubility
Soluble in DMSO (Slightly), Methanol (Slightly)